Category: Terumo Corp.
Vascular Solutions agrees to settle a patent infringement beef with Terumo over its R Band hemostasis device for $812,000 and a promise that Terumo won't sue over its Vasc Band device.
Medical device companies including Cardinal Health and Mindray Medical are among the firms awarded contracts and extensions worth nearly $196 million by the U.S. Defense Dept.
The U.S. Defense Dept. awarded $195.8 million worth of contracts to 3 medical device firms.
Thoratec pays $13 million up front to acquire Terumo's DuraHeart II heart pump, with possible milestones down the road worth nearly $44 million.
InspireMD nets nearly $23 million from a public stock offering, saying it plans to use the proceeds to pursue U.S. approval of its MGuard coronary and carotid stents.
InspireMD (OTC:NSPR) said it added some $23 million to its coffers in a public stock offering.
The Tel Aviv-based medical device company makes the MGuard device, designed to protect against embolism after stenting procedures.
It was a big week for medical device company Medtronic's Symplicity renal denervation device for treating high blood pressure, with the release of new clinical data and a pair of regulatory developments for the device.
It was a big week for Medtronic (NYSE:MDT) and its Symplicity high blood pressure device, with the release of 2-year clinical data and a pair of regulatory developments for the renal denervation system.
Japanese medical device company Terumo says it's spiking a distribution deal with Boston Scientific for its GlideWire urological catheter guidewire.
On the heels of gaping losses and a more than 25% sales decline, Accuray announces plans for a $75 million debt round.
Accuray (NSDQ:ARAY) plans to issue $75 million worth of convertible senior notes as it gears up to restructure its business after a year of widening losses.
The Sunnyvale, Calif.-based medical device company said it will use the proceeds from the offering of debt due Feb. 1, 2018, to shore up its balance sheet.